GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 127 filers reported holding GOSSAMER BIO INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $877,272 | -57.1% | 1,053,400 | -38.1% | 0.00% | -60.0% |
| Q2 2023 | $2,043,480 | -11.9% | 1,702,900 | -7.5% | 0.01% | -16.7% |
| Q1 2023 | $2,318,904 | -41.4% | 1,840,400 | +0.9% | 0.01% | -45.5% |
| Q4 2022 | $3,959,599 | -61.9% | 1,824,700 | +110.3% | 0.01% | -63.3% |
| Q3 2022 | $10,395,000 | +307.0% | 867,700 | +184.4% | 0.03% | +328.6% |
| Q2 2022 | $2,554,000 | -1.2% | 305,100 | +2.5% | 0.01% | 0.0% |
| Q1 2022 | $2,585,000 | -13.8% | 297,800 | +12.3% | 0.01% | -12.5% |
| Q4 2021 | $2,999,000 | +17.2% | 265,200 | +30.3% | 0.01% | +14.3% |
| Q3 2021 | $2,559,000 | -12.2% | 203,600 | -43.2% | 0.01% | -12.5% |
| Q2 2021 | $2,913,000 | -35.8% | 358,700 | -26.8% | 0.01% | -33.3% |
| Q1 2021 | $4,534,000 | +133.5% | 490,200 | +144.1% | 0.01% | +140.0% |
| Q4 2020 | $1,942,000 | +3.9% | 200,800 | +33.2% | 0.01% | 0.0% |
| Q3 2020 | $1,870,000 | +167.9% | 150,700 | +180.6% | 0.01% | +150.0% |
| Q2 2020 | $698,000 | – | 53,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |